View in EDS

Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.

Saved in:
Bibliographic Details
Title: Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.
Authors: Bayó C; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain., Castellano G; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain., Marín F; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain., Castillo-Iturra J; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Ocaña T; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Kumari H; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Pellisé M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Moreira L; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Rivero L; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Daca-Alvarez M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Ortiz O; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Carballal S; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Moreira R; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Canet-Hermida J; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain., Pineda M; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain., Gabriel C; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain., Flórez-Grau G; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain., Juan M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Immunology, Servei d'Immunologia. Hospital Clínic de Barcelona, Barcelona, Barcelona, Spain., Benitez-Ribas D; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Balaguer F; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain francescbalaguer@ub.edu.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salud, Universitat de Barcelona (UB), Barcelona, Spain.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 20; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 20.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40254392
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bayó+C%22">Bayó C</searchLink>; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Castellano+G%22">Castellano G</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Marín+F%22">Marín F</searchLink>; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castillo-Iturra+J%22">Castillo-Iturra J</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Ocaña+T%22">Ocaña T</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Kumari+H%22">Kumari H</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Pellisé+M%22">Pellisé M</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Moreira+L%22">Moreira L</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Rivero+L%22">Rivero L</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Daca-Alvarez+M%22">Daca-Alvarez M</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Ortiz+O%22">Ortiz O</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Carballal+S%22">Carballal S</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Moreira+R%22">Moreira R</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Canet-Hermida+J%22">Canet-Hermida J</searchLink>; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pineda+M%22">Pineda M</searchLink>; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gabriel+C%22">Gabriel C</searchLink>; Hereditary Cancer Program, Catalan institute of oncology, IDIBELL, Badalona, Catalunya, Spain.; Consortium for Biomedical Research in Cancer, Carlos III Institute of Health, CIBERONC, Madrid, Comunidad de Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Flórez-Grau+G%22">Flórez-Grau G</searchLink>; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Juan+M%22">Juan M</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain.; Immunology, Servei d'Immunologia. Hospital Clínic de Barcelona, Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Benitez-Ribas+D%22">Benitez-Ribas D</searchLink>; Immunology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Balaguer+F%22">Balaguer F</searchLink>; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain francescbalaguer@ub.edu.; Gastroenterology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salud, Universitat de Barcelona (UB), Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Apr 20; Vol. 13 (4). <i>Date of Electronic Publication: </i>2025 Apr 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40254392
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-011177
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bayó C
      – PersonEntity:
          Name:
            NameFull: Castellano G
      – PersonEntity:
          Name:
            NameFull: Marín F
      – PersonEntity:
          Name:
            NameFull: Castillo-Iturra J
      – PersonEntity:
          Name:
            NameFull: Ocaña T
      – PersonEntity:
          Name:
            NameFull: Kumari H
      – PersonEntity:
          Name:
            NameFull: Pellisé M
      – PersonEntity:
          Name:
            NameFull: Moreira L
      – PersonEntity:
          Name:
            NameFull: Rivero L
      – PersonEntity:
          Name:
            NameFull: Daca-Alvarez M
      – PersonEntity:
          Name:
            NameFull: Ortiz O
      – PersonEntity:
          Name:
            NameFull: Carballal S
      – PersonEntity:
          Name:
            NameFull: Moreira R
      – PersonEntity:
          Name:
            NameFull: Canet-Hermida J
      – PersonEntity:
          Name:
            NameFull: Pineda M
      – PersonEntity:
          Name:
            NameFull: Gabriel C
      – PersonEntity:
          Name:
            NameFull: Flórez-Grau G
      – PersonEntity:
          Name:
            NameFull: Juan M
      – PersonEntity:
          Name:
            NameFull: Benitez-Ribas D
      – PersonEntity:
          Name:
            NameFull: Balaguer F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 04
              Text: 2025 Apr 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1